POM Investment Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65K Sell
19
-30
-61% -$2.87K ﹤0.01% 381
2025
Q4
$4.71K Buy
+49
New +$4.76K ﹤0.01% 207
2025
Q2
Sell
-33
Closed -$2.96K 194
2025
Q1
$2.96K Sell
33
-60
-65% -$5.37K ﹤0.01% 134
2024
Q4
$7.43K Buy
93
+30
+48% +$2.6K 0.01% 195
2024
Q3
$5.67K Buy
63
+2
+3% +$168 ﹤0.01% 169
2024
Q2
$4.8K Buy
61
+28
+85% +$2.29K ﹤0.01% 224
2024
Q1
$2.88K Hold
33
﹤0.01% 166
2023
Q4
$2.72K Buy
+33
New +$2.52K ﹤0.01% 158

Other funds holding MDT

POM Investment Strategies's MDT Position: Q1 2026 in Review

POM Investment Strategies reduced its Medtronic (MDT) stake by 61% in Q1 2026, selling an estimated $2.87K and leaving 19 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

POM Investment Strategies first reported a position in MDT in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.43K in Q4 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • POM Investment Strategies held 19 shares of Medtronic worth $1.65K as of Q1 2026.
  • POM Investment Strategies sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
  • Medtronic made up ﹤0.01% of POM Investment Strategies's portfolio in Q1 2026, its #381 holding.
  • POM Investment Strategies first reported a position in Medtronic in Q4 2023 and has held it in 8 quarters since.
  • POM Investment Strategies's Medtronic position peaked at $7.43K in Q4 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on POM Investment Strategies's 13F filing for Q1 2026, filed 11 May 2026.